An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
A person asked whether taking a GLP‑1 weight-loss drug (the same class as semaglutide, the active ingredient in Ozempic and Wegovy) could change how well their oral antidepressant (an SSRI) works. They’re 70 pounds overweight and hoping a doctor will prescribe a GLP‑1 but worry that because these drugs slow how fast the stomach empties, that might change how other pills are absorbed and whether they still work. GLP‑1 drugs are medicines that copy a natural gut hormone. They make you feel less hungry, help you feel full sooner, and slow the movement of food from the stomach into the intestines (that’s called delayed gastric emptying). Semaglutide is one of the best‑known examples. SSRIs are a common class of antidepressants you swallow as a pill. They work in the brain to change levels of certain brain chemicals and usually need to get absorbed from the gut into the bloodstream to reach the brain. What the evidence says is mixed and not dramatic. Slower stomach emptying can change how quickly and sometimes how much of an oral drug gets into your blood. For many common pills, a modest delay in absorption doesn’t change the overall effect. Studies and reports looking specifically at GLP‑1s with SSRIs are limited. Some people report mild changes like feeling their antidepressant kicks in slower or having more stomach upset at first, but large clinical trials have not flagged a consistent loss of antidepressant effect caused by GLP‑1s. In short: it’s possible absorption is altered a bit, but strong proof that SSRIs stop working when you start a GLP‑1 is lacking. Why this matters is practical. If you’re on an SSRI and considering a GLP‑1 for weight, you and your prescriber should watch mood symptoms and side effects closely after starting the new drug. Small absorption changes could matter for people on medications with a narrow safe range, or for those whose depression is fragile. Most people won’t need a change in their SSRI, but a follow‑up plan—extra check‑ins, tracking mood, and knowing what to do if symptoms return—is wise. Caveats: this is not medical advice, and the data aren’t definitive. Side effects of GLP‑1s include nausea, vomiting, and changes in digestion; those could temporarily affect how you tolerate other meds. Some SSRIs and other drugs can also interact in different ways, so don’t stop or change doses without talking to your doctor or pharmacist. If your depression symptoms worsen after starting a GLP‑1, contact your prescriber promptly. Bottom line: there’s a plausible reason absorption could change, but major loss of SSRI effectiveness hasn’t been clearly proven—monitoring and doctor guidance are the right steps.
Source: r/Semaglutide